id:"swepub:oai:DiVA.org:uu-89156"
Search: id:"swepub:oai:DiVA.org:uu-89156" > Regeneration of hum...
- 1 of 1
- Previous record
- Next record
- To hitlist
- Forsberg, SofiUppsala universitet,Dermatologi och venereologi (author)
Regeneration of human epidermis on acellular dermis is impeded by small-molecule inhibitors of EGF receptor tyrosine kinase
- Article/chapterEnglish2008
Publisher, publication year, extent ...
- 2008-04-30
- Springer Science and Business Media LLC,2008
- printrdacarrier
Numbers
- LIBRIS-ID:oai:DiVA.org:uu-89156
- https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-89156URI
- https://doi.org/10.1007/s00403-008-0853-2DOI
- http://kipublications.ki.se/Default.aspx?queryparsed=id:117632362URI
Supplementary language notes
- Language:English
- Summary in:English
Part of subdatabase
- SwePubSwePub
Classification
Notes
- The family of human epidermal growth factor receptors (EGFR, HER2-4) exerts key functions in normal and malignant epithelial cells. Both EGFR and HER2 are valuable targets for anti-cancer drugs by interfering with ligand binding, receptor dimerization, or tyrosine kinase activity. A similar therapeutic strategy has been advocated for chronic psoriasis since plaque lesions overexpress EGFR and its ligands. Our aim was to characterize EGFR/HER2 protein expression in skin cultures and to evaluate the effects of tyrosine kinase inhibitors on epidermal outgrowth, morphology, and EGFR activation. Human skin explants were established on cell-free dermis and cultured at the air-liquid interface. The impact of small-molecule HER inhibitors on outgrowth was assayed by fluorescence-based image analysis and histometry. Effects of a dual EGFR/HER2 kinase inhibitor, PKI166, on neoepidermis were studied by immunohistochemistry and Western blot. Receptor immunostaining showed in vivo-like distributions with highest EGFR intensity in the proliferative layers whereas HER2 was mainly expressed by suprabasal keratinocytes. Reepithelialization was associated with EGFR autophosphorylation irrespective of exogenous ligand stimulation. PKI166 inhibited neoepidermal EGFR activation, keratinocyte proliferation, and outgrowth from normal and psoriatic skin explants. The rate of epidermalization in presence of other HER inhibitors varied suggesting that drug specificity, potency, and reversibility determine the dynamic outcome. Overall, agents predominantly targeting EGFR kinase were more efficient inhibitors of epidermal regeneration than an HER2-selective drug. The study illustrates the usefulness of a dynamic skin model and emphasizes the potential of HER-directed approaches to control epidermal growth in hyperproliferative skin disorders.
Subject headings and genre
- MEDICIN OCH HÄLSOVETENSKAP Klinisk medicin Dermatologi och venereologi hsv//swe
- MEDICAL AND HEALTH SCIENCES Clinical Medicine Dermatology and Venereal Diseases hsv//eng
- Dermatology and venerology
- Dermatologi och venerologi
Added entries (persons, corporate bodies, meetings, titles ...)
- Östman, ArneKarolinska Institutet (author)
- Rollman, OlaUppsala universitet,Dermatologi och venereologi(Swepub:uu)olarollm (author)
- Uppsala universitetDermatologi och venereologi (creator_code:org_t)
Related titles
- In:Archives of Dermatological Research: Springer Science and Business Media LLC300:9, s. 505-5160340-36961432-069X
Internet link
Find in a library
- Archives of Dermatological Research (Search for host publication in LIBRIS)
To the university's database
- 1 of 1
- Previous record
- Next record
- To hitlist
Find more in SwePub
- By the author/editor
- Forsberg, Sofi
- Östman, Arne
- Rollman, Ola
- About the subject
-
- MEDICAL AND HEALTH SCIENCES
- MEDICAL AND HEAL ...
- and Clinical Medicin ...
- and Dermatology and ...
- Articles in the publication
- Archives of Derm ...
- By the university
- Uppsala University
- Karolinska Institutet
Search outside SwePub
- Extend your search to:
- Google Book Search
- Google Scholar
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
- Copyright © LIBRIS - National Library Systems
- LIBRIS.kb.se
